Population Pharmacokinetics of Gentamicin in Neonates
- 1 July 1988
- journal article
- research article
- Published by S. Karger AG in Developmental Pharmacology and Therapeutics
- Vol. 11 (3) , 173-179
- https://doi.org/10.1159/000457685
Abstract
The influence of a number of clinical characteristics on the population pharmacokinetics of gentamicin were examined using routine drug-monitoring data from a group of 113 neonates. The data were analyzed using the programme NONMEM. Clearance was 0.053 litres∙h^-1∙kg^-1 and was reduced in neonates with postconceptional age <34 weeks (X 0.83) and 5-min Apgar score < 7 (X 0.82). Volume of distribution was 0.47 litres∙kg^-1. These population mean parameter estimates were used to generate dosage regimens to achieve concentrations within the therapeutic range.Keywords
This publication has 7 references indexed in Scilit:
- Postconceptional age and gentamicin elimination half-lifeThe Journal of Pediatrics, 1985
- Gentamicin Disposition and Effect on Development of Renal Function in the Very Low Birth Weight InfantDevelopmental Pharmacology and Therapeutics, 1984
- Estimating glomerular filtration rate in infantsThe Journal of Pediatrics, 1984
- Plasma creatinine in the first month of life.Archives of Disease in Childhood, 1982
- Two-compartment gentamicin pharmacokinetics in premature neonates: A comparison to adults with decreased glomerular filtration ratesThe Journal of Pediatrics, 1980
- Why Monitor Serum Levels of Gentamicin?Clinical Pharmacokinetics, 1978
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977